Clinical Trial Update: ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating 0.75% bupivacaine for bilateral tubal ligation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• bupivacaine 0.75% (bupivacaine)

Snippet

Sponsor: Duke University | Conditions: Pain | Phase 4 | Status: WITHDRAWN